@BOOK{NAP author = "National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine", editor = "Ravi Anupindi and Prashant Yadav and Kenisha M.P. Jefferson and Elizabeth Ashby", title = "Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines", isbn = "978-0-309-08915-9", abstract = "Influenza viruses, both seasonal and pandemic, have the potential to disrupt the health and well-being of populations around the world. The global response to the COVID-19 pandemic and prior public health emergencies of international concern illustrate the importance of global preparedness and coordination among governments, academia, scientists, policy makers, nongovernmental organizations, the private sector, and the public to address the threat of pandemic influenza. These health emergencies have revealed opportunities to enhance global vaccine infrastructure, manufacturing, distribution, and administration.\nGlobally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines outlines key findings and recommendations to bolster vaccine distribution, manufacturing, and supply chains for future seasonal and pandemic influenza events. This report addresses the challenges of manufacturing and distributing vaccines for both seasonal and pandemic influenza, highlighting the critical components of vaccine manufacturing and distribution and offering recommendations that would address gaps in the current global vaccine infrastructure.", url = "https://nap.nationalacademies.org/catalog/26285/globally-resilient-supply-chains-for-seasonal-and-pandemic-influenza-vaccines", year = 2022, publisher = "The National Academies Press", address = "Washington, DC" } @BOOK{NAP author = "National Academies of Sciences, Engineering, and Medicine", editor = "Alison Mack", title = "Impact of the Global Medical Supply Chain on SNS Operations and Communications: Proceedings of a Workshop", isbn = "978-0-309-47774-1", abstract = "The Centers for Disease Control and Prevention (CDC) established the Strategic National Stockpile (SNS) with a focus on procuring and managing medical countermeasures (MCM) designed to address chemical, biological, radiological, and nuclear events and attacks by weapons of mass destruction. The stockpile is a repository of antibiotics, chemical antidotes, antitoxins, vaccines, antiviral drugs, and other medical materiel organized to respond to a spectrum of public health threats. Over time, the mission of the SNS has informally evolved to address other large-scale catastrophes, such as hurricanes or outbreaks of pandemic disease, and rare acute events, such as earthquakes or terror attacks. When disaster strikes, states can request deployment of SNS assets to augment resources available to state, local, tribal, or territorial public health agencies. CDC works with federal, state, and local health officials to identify and address their specific needs and, according to the stated mission of the SNS, ensure that the right resources reach the right place at the right time.\n\nOn August 28, 2017, the National Academies of Sciences, Engineering, and Medicine convened a workshop to explore the current state of the global medical supply chain as it relates to SNS assets, and the role of communications in mitigating supply chain risks and in enhancing the resilience of MCM distribution efforts. This publication summarizes the presentations and discussions from the workshop.", url = "https://nap.nationalacademies.org/catalog/25149/impact-of-the-global-medical-supply-chain-on-sns-operations-and-communications", year = 2018, publisher = "The National Academies Press", address = "Washington, DC" } @BOOK{NAP author = "National Academies of Sciences, Engineering, and Medicine", editor = "Anna Nicholson and Evan Randall and Lisa Brown and Carolyn Shore and Benjamin Kahn", title = "The Security of America's Medical Product Supply Chain: Considerations for Critical Drugs and Devices: Proceedings of a Workshop—in Brief", abstract = "Recent disasters and health emergencies, including the COVID-19 pandemic, have shed light on the fragility of the U.S. medical supply chain and underscored the need to explore policy, regulatory, and systems solutions to prevent and mitigate the impacts of shortages on public health, national security, and patient care. Under the Coronavirus Aid, Relief, and Economic Security (CARES) Act, the National Academies of Sciences, Engineering, and Medicine established an ad hoc committee to examine the security and resilience of the U.S. medical product supply chain. Specifically, the committee was asked to assess and evaluate the impact of U.S. dependence on critical drugs and devices sourced or manufactured outside the U.S. and provide recommendations to improve the resilience and address the vulnerabilities of the medical supply chain.\nOn December 1 and 2, 2020, the Committee on Security of America's Medical Product Supply Chain held a two-day virtual public workshop focused on assessing lists of critical and essential medical products. The workshop sought to conceptually explore how critical and essential medical product lists are developed and used in practice. The committee's consensus study report will be available in 2022. This Proceedings of a Workshop-in Brief summarizes the discussions that occurred at the workshop.", url = "https://nap.nationalacademies.org/catalog/26137/the-security-of-americas-medical-product-supply-chain-considerations-for", year = 2021, publisher = "The National Academies Press", address = "Washington, DC" }